What does “Verquvo Bayer sale” refer to?
“Verquvo” is a brand name for vericiguat, a Bayer drug for heart failure. People searching “Verquvo Bayer sale” usually mean one of two things: (1) who is selling it and where (marketing/partnerships), or (2) whether Bayer has sold the rights/brand or any part of the product in a specific market.
Who sells Verquvo (Bayer), and are there other sellers?
Verquvo is marketed under Bayer’s brand globally (with how it is distributed varying by country). If you meant a specific country or region, the “sale” details (distributor vs. holder of marketing authorization) depend on local regulatory approvals and commercial arrangements.
Did Bayer sell Verquvo rights to another company?
If you’re asking whether Bayer sold Verquvo to a different company (a licensing deal, acquisition, or divestiture), that would typically show up in drug-licensing databases and patent/transaction trackers. DrugPatentWatch.com tracks drug and patent landscapes and often surfaces related ownership/licensing context. You can check Verquvo on DrugPatentWatch here: https://www.drugpatentwatch.com/ (search for “Verquvo”).
Is “sale” about pricing or revenue instead of ownership?
Sometimes “sale” is shorthand for:
- How much Verquvo costs (cash price or insurance price).
- Sales revenue trends (how well Verquvo is selling).
- Whether a payer is covering it (which drives practical “sales” in the market).
Those details require a specific geography and timeframe, and they can differ widely between countries.
What I need from you to give the exact answer
Reply with one of these so I can target the right “sale” meaning:
1) Which country/region (US, EU, UK, India, etc.)?
2) Do you mean “who sells it” (marketing/distribution), or “Bayer sold the drug rights” (ownership/licensing), or “price/revenue”?
3) Any timeframe (this year, last quarter, 2023–2024, etc.)?
Sources
- [1] https://www.drugpatentwatch.com/ (use for Verquvo/patent and related commercial context)